Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.6.0.2
Segment Information
3 Months Ended
Nov. 30, 2016
Segment Information [Text Block]
16.

Segment Information

The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and our chief operating decision makers, being our president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health products as well as licensing, as a whole, to make operational decisions and to assess the performance of the Company. Accordingly, the Company operates in a single segment.